What's Next for Pharma?
What’s Next for Pharma? Experts from the Tufts Center for the Study of Drug Development discuss the outlook for R&D, […]
What’s Next for Pharma? Experts from the Tufts Center for the Study of Drug Development discuss the outlook for R&D, […]
What’s Next for Pharma? Experts from the Tufts Center for the Study of Drug Development discuss the outlook for R&D,
India: Big Pharma’s New Promised Land? For years, software companies have known that they can slash costs by hiring eager,
India: Big Pharma’s New Promised Land? For years, software companies have known that they can slash costs by hiring eager,
Genetically engineered Glofish spark controversy The nation’s first genetically engineered pet glows in the dark and has been lighting up
Genetically engineered Glofish spark controversy Read Post »
Feeling Lucky? Counterfeiters have moved beyond bogus currency and fake designer handbags into the lucrative world of prescription drugs, setting
Biotech industry raises $16.4B in new funding in 2003 The biotechnology industry raised $16.4 billion in new financing and earned
Biotech industry raises $16.4B in new funding in 2003 Read Post »
Baby Steps New work shows the promise, and pitfalls, of embryonic-stem-cell research
A Happy Pill for Some Biotechs Analysts predict 2003’s rally will continue, with the winners changing to include a few
Biotech: A Coming Boom — or Bust? Two industry veterans lay out contrasting views about what the sector and its
Get new actionable insights and updates from BiotechBlog